The unexpected discovery may provide scientists with new insights into how cancer develops — and how to combat it.

Discontinuing tyrosine kinase inhibitor maintenance after extended complete molecular response should only be attempted as part of a clinical trial, the researchers say.

Oct. 9, 2024 — Researchers have created a CRISPR-based rapid molecular diagnostic for two forms of leukemia that are driven by mutations that involve gene fusions. The technology accurately ...

In addition to exporting materials out of the nucleus, the protein, called Exportin-1 (also called Xpo1 or Crm1), seems to play a role in promoting gene transcription, the process that creates RNA ...

“Understanding how the repertoire of immune cells fits with the diverse landscape of brain cancer types can help us find new ...

Duke University blood cancer specialist Lindsay Rein, MD, has developed a rare expertise in myeloproliferative neoplasms ...

Identifying the JAK2V617F mutation has improved understanding of what causes overproduction of red blood cells, platelets, ...

Researchers from Northwestern University have stumbled upon a previously unobserved function of a protein found in the cell ...

Scientists compared blood from frequent, long-term donors to that of more seldom ones and saw some key genetic differences in ...

Maria Branyas lived to be a whopping 117 years old and ticked many of the boxes for longevity, according to researchers.

Researchers and pediatric neurosurgeons at the University of Pittsburgh School of Medicine and UPMC Children's Hospital of ...